Icahn School Of Medicine At Mount Sinai: $4.2B Revenue, $3.2B Program Expenses

Icahn School Of Medicine At Mount Sinai earns an A on the nonprofit efficiency rubric — a top-tier rating that reflects strong program-spending ratios, reasonable executive compensation, and stable financial reserves. The composite score of 83/100 places it in the upper bracket of U.S. tax-exempt organizations.

On revenue, Icahn School Of Medicine At Mount Sinai is among the largest U.S. nonprofits: $4.2B in 2023 reported revenue. Organizations at this scale typically operate hospitals, university systems, or national federations — the financial pattern looks more like a corporation than the small-charity stereotype. Program-spending efficiency is strong: 80% of total expenses flow to program activities, above the 75% benchmark most third-party charity raters use.

Revenue has grown meaningfully across the five-year filing history — a sign of expanding donor base, new grants, or scaling programs. Icahn School Of Medicine At Mount Sinai reported $4.2B in 2023, up notably from the start of the window. CEO compensation is reported as zero in the filing — typical for nonprofits where the chief executive is paid through a related entity (parent system, university, or foundation) rather than the filing organization itself, or for small organizations whose chief is a volunteer or board member. In the Education category, Icahn School Of Medicine At Mount Sinai sits alongside universities, K-12 systems, scholarship funds, and education-research organizations. Education-sector nonprofits often hold large endowments, which affects how the reserves-and-revenue ratios should be read.